Identification of pediatric septic shock subclasses based on genome-wide expression profiling

BMC Medicine

Volumn 7, Issue , 2009, Pages

  Wong, Hector R ^a   Cvijanovich, Natalie ^b   Lin, Richard ^c   Allen, Geoffrey L ^d   Thomas, Neal J ^e   Willson, Douglas F ^f   Freishtat, Robert J ^g   Anas, Nick ^h   Meyer, Keith ⁱ   Checchia, Paul A ^j   Monaco, Marie ^a   Odom, Kelli ^a   Shanley, Thomas P ^k  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e PENN STATE CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

ⁱ MIAMI CHILDREN'S HOSPITAL   (United States)

^j ST LOUIS CHILDREN S HOSPITAL   (United States)

^k UNIVERSITY OF MICHIGAN   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; BLOOD CELL; CHEMISTRY; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; PRESCHOOL CHILD; SEPTIC SHOCK; STATISTICAL ANALYSIS;

BLOOD CELLS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; SHOCK, SEPTIC;

EID: 70349239233     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-7-34     Document Type: Article

References (42)

1. Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ, Faist E, Reinhart K. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003, 31:1560-1567. 10.1097/01.CCM.0000065186.67848.3A, 12771633.
2. Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998, 102:e19. 10.1542/peds.102.2.e19, 9685464.
3. Jellema WT, Groeneveld AB, Wesseling KH, Thijs LG, Westerhof N, van Lieshout JJ. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock. Crit Care Med 2006, 34:2392-2398. 10.1097/01.CCM.0000233871.52553.CD, 16849997.
4. Brierley J, Peters MJ. Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care. Pediatrics 2008, 122:752-759. 10.1542/peds.2007-1979, 18829798.
5. Reinhart K, Wiegand-Lohnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 1996, 24:733-742. 10.1097/00003246-199605000-00003, 8706447.
6. Reinhart K, Menges T, Gardlund B, Harm Zwaveling J, Smithes M, Vincent JL, Tellado JM, Salgado-Remigio A, Zimlichman R, Withington S, Tschaikowsky K, Brase R, Damas P, Kupper H, Kempeni J, Eiselstein J, Kaul M. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med 2001, 29:765-769. 10.1097/00003246-200104000-00015, 11373466.
7. Wong HR, Cvijanovich N, Wheeler DS, Bigham MT, Monaco M, Odoms K, Macias WL, Williams MD. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008, 178:276-282. 10.1164/rccm.200801-131OC, 18511707.
8. Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, Xiao W, Laudanski K, Brownstein BH, Elson CM, Hayden DL, Herndon DN, Lowry SF, Maier RV, Schoenfeld DA, Moldawer LL, Davis RW, Tompkins RG, Bankey P, Billiar T, Camp D, Chaudry I, Freeman B, Gamelli R, Gibran N, Harbrecht B, Heagy W, Heimbach D, Horton J, Hunt J, Lederer J, Mannick J, McKinley B, Minei J, Moore E, Moore F, Munford R, Nathens A, O'Keefe G, Purdue G, Rahme L, Remick D, Sailors M, Shapiro M, Silver G, Smith R, Stephanopoulos G, Stormo G, Toner M, Warren S, West M, Wolfe S, Young V. Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci USA 2005, 102:4801-4806. 555033, 15781863, 10.1073/pnas.0409768102.
9. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Shanley TP. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009, 37:1558-1566. 10.1097/CCM.0b013e31819fcc08, 19325468.
10. Wong HR. Pediatric septic shock treatment: new clues from genomic profiling. Pharmacogenomics 2007, 8:1287-1290. 10.2217/14622416.8.10.1287, 17979501.
11. Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, Tagavilla MA, Odoms K, Dunsmore K, Barnes M, Aronow BJ. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007, 30:146-155. 10.1152/physiolgenomics.00024.2007, 17374846.
12. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, Odoms K, Barnes M, Sakthivel B, Aronow BJ, Wong HR. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007, 13:495-508. 2014731, 17932561, 10.2119/2007-00065.Shanley.
13. Cvijanovich N, Shanley TP, Lin R, Allen GL, Thomas NJ, Checchia P, Anas N, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Wong HR. Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008, 34:127-134. 2440641, 18460642, 10.1152/physiolgenomics.00025.2008.
14. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6:2-8. 10.1097/01.PCC.0000149131.72248.E6, 15636651.
15. Pollack MM, Patel KM, Ruttimann UE. The Pediatric Risk of Mortality III - Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 1997, 131:575-581. 10.1016/S0022-3476(97)70065-9, 9386662.
16. Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS. Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986, 14:271-274.
17. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
18. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037. 10.1038/nature03985, 16136080.
19. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
20. Daffertshofer A, Lamoth CJ, Meijer OG, Beek PJ. PCA in studying coordination and variability: a tutorial. Clin Biomech (Bristol, Avon) 2004, 19:415-428. 10.1016/j.clinbiomech.2004.01.005, 15109763.
21. Do JH, Choi DK. Clustering approaches to identifying gene expression patterns from DNA microarray data. Mol Cells 2008, 25:279-288.
22. Noble WS. What is a support vector machine?. Nat Biotechnol 2006, 24:1565-1567. 10.1038/nbt1206-1565, 17160063.
23. Abraham E. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 1999, 25:556-566. 10.1007/s001340050903, 10416906.
24. Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood 2004, 104:923-932. 10.1182/blood-2004-01-0274, 15155462.
25. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537. 10.1126/science.286.5439.531, 10521349.
26. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001, 98:15149-15154. 64998, 11742071, 10.1073/pnas.211566398.
27. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947. 10.1056/NEJMoa012914, 12075054.
28. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 58566, 11553815, 10.1073/pnas.191367098.
29. Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967, 12490681.
30. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006, 7:55-65. 10.1038/nrg1749, 16369572.
31. Nadon R, Shoemaker J. Statistical issues with microarrays: processing and analysis. Trends Genet 2002, 18:265-271. 10.1016/S0168-9525(02)02665-3, 12047952.
32. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003, 167:695-701. 10.1164/rccm.200207-682OC, 12433670.
33. Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, Sundin DP, Giroir B. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007, 369:836-843. 10.1016/S0140-6736(07)60411-5, 17350452.
34. Annane D, Fan E, Herridge MS. Pro-con debate: steroid use in ACTH non-responsive septic shock patients with high baseline cortisol levels. Crit Care 2006, 10:210. 1550911, 16620371, 10.1186/cc4856.
35. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005, 174:3765-3772.
36. Heidecke CD, Hensler T, Weighardt H, Zantl N, Wagner H, Siewert JR, Holzmann B. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 1999, 178:288-292. 10.1016/S0002-9610(99)00183-X, 10587185.
37. Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003, 35:585-592. 10.1080/00365540310015692, 14620139.
38. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
39. Perry SE, Mostafa SM, Wenstone R, Shenkin A, McLaughlin PJ. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?. Intensive Care Med 2003, 29:1245-1252. 10.1007/s00134-003-1686-2, 12774155.
40. Frazier WJ, Hall MW. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 2008, 55:647-668. 2474674, 18501759, 10.1016/j.pcl.2008.02.009.
41. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004, 24:277-298. 10.1146/annurev.nutr.24.012003.132454, 15189122.
42. Ibs KH, Rink L. Zinc-altered immune function. J Nutr 2003, (Suppl 1):1452S-1456S.